BlackBarn Capital Partners
BlackBarn Capital Partners reported 17 stocks worth $402M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are ROIV (17.6%), PRVA (10.1%) and DHC (9.4%). Compared with Q1 2026, the fund opened new positions in UNH, VG and AZUL, added to NIQ, NXPI and MH, trimmed ROIV, DHC and VKTX and sold out of VECO.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  ROIV Roivant Sciences Ltd | $70.8M | 17.6% | 2M | −285K (−12%) | 8 of 8 | |
| 2 |  PRVA Privia Health Group Inc | $40.8M | 10.1% | 1.6M | No change | 8 of 8 | |
| 3 |  DHC Diversified Healthcare TR | $37.9M | 9.4% | 4.1M | −737K (−15%) | 8 of 8 | |
| 4 |  NEE Nextera Energy Inc | $29.4M | 7.3% | 335K | No change | 5 of 8 | |
| 5 |  NIQ Niq Global Intelligence PLC | $27.2M | 6.8% | 2.9M | +829K (+40%) | 3 of 8 | |
| 6 |  UNH Unitedhealth Group Inc | $27M | 6.7% | 65K | New position | 4 of 8 | |
| 7 |  NXPI Nxp Semiconductors N V | $25.3M | 6.3% | 90K | +30K (+50%) | 2 of 8 | |
| 8 |  VKTX Viking Therapeutics Inc | $23.4M | 5.8% | 600K | −21K (−3%) | 5 of 8 | |
| 9 |  MH McGraw Hill Inc | $23.2M | 5.8% | 2.5M | +362K (+17%) | 4 of 8 | |
| 10 |  AMRX Amneal Pharmaceuticals Inc | $22.5M | 5.6% | 1.3M | −350K (−21%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 VECO Veeco Instrs Inc Del | $33.9M | 1M |
GLOBAL BUSINESS TRAVEL GROUP | $11.2M | 2M |
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 SPY Spdr S&P 500 ETF TR | Put | $597M | 800K | 0 |
 OSCR Oscar Health Inc | Put | $49.9M | 1.8M | +1,750,000 |
UNH Unitedhealth Group Inc | Call | $41.6M | 100K | +100,000 |
 RMD Resmed Inc | Put | $39M | 200K | −200,000 |
 VG Venture Global Inc Class Class A | Call | $33.4M | 3M | +3,000,000 |
🔒 Free account: see all 7.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →BlackBarn Capital Partners 13F FAQ
What does BlackBarn Capital Partners own?
BlackBarn Capital Partners reported 17 stocks worth $402M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are ROIV (17.6%), PRVA (10.1%) and DHC (9.4%). The table above lists every position in the filing (the top 10 without an account).
What did BlackBarn Capital Partners buy and sell in Q2 2026?
Compared with Q1 2026: 5 new positions, 3 added to, 5 trimmed and 2 sold out. New positions include UNH, VG and AZUL. It sold all of VECO.
When will BlackBarn Capital Partners file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is BlackBarn Capital Partners's portfolio worth?
The Q2 2026 filing reports $402M in US stocks ($1.2B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.